Skip to content

Clinical efficacy and proteomic study of electroacupuncture in type III prostatitis

Clinical efficacy and proteomic study of electroacupuncture in type III prostatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000661
Enrollment
Unknown
Registered
2025-04-06
Start date
2025-04-10
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic prostatitis/chronic pelvic pain syndromes CP / CPPS

Interventions

electroacupuncture group:Patients lying on their sides, with 75% alcohol disinfection of the locus, needling until the patient has to the head of the penis to go to the radiating sensation and other s
Placebo needle group:The same acupoints were selected for the same duration of intervention as the electroacupuncture and the method of Placebo needle was: needling with a blunt-tipped needle (the pa

Sponsors

School of Acupuncture and Tuina Beijing University o Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 69 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for chronic prostatitis (Type III prostatitis) with a score of at least 15 on the NIH-CPSI scale; (2) Male age between 18 and 69 years; (3) Pelvic area pain or discomfort lasting at least 3 months accompanied by lower urinary tract symptoms and/or sexual dysfunction.

Exclusion criteria

Exclusion criteria: (1) Other types of prostatitis combined genitourinary infections bladder outlet obstruction overactive bladder interstitial cystitis inflammatory bowel disease benign prostatic hyperplasia varicose veins of the spermatic cord urinary tumours and other urological diseases; (2) Combined with other diseases such as heart disease serious cardiovascular and cerebrovascular disease liver and renal insufficiency haematopoietic system disease mental illness etc; (3) Taking medication to relieve symptoms of CP/CPPS or receiving non-pharmacological therapy within the last four weeks; (4) Presence of any contraindications to acupuncture injury or infection at the site of needle application or systemic disease at the site of needle application that is considered by the researcher to be unsuitable for the measures to be taken;

Design outcomes

Primary

MeasureTime frame
effective response rate;

Secondary

MeasureTime frame
Prostate fluid routine;Prostate ultrasound;Self-rating anxiety scale;Self-rating depression scale;urine flow rate;visual analogue scale;National Institutes of Health Chronic Prostatitis Symptom Index;

Countries

China

Contacts

Public ContactLi Na

Beijing University of Chinese Medicine

201901035@bucm.edu.cn15210722947

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026